Loading...
Loading...
In a report published Friday, Jefferies & Company reiterated its Hold rating on IPC The Hospitalist Company
IPCM, but lowered its price target from $47.00 to $40.00.
Jefferies noted, “IPC's Q3 miss -- driven by contract exits and volume weakness in the company's host hospitals -- and associated guidance cut puts the stock back in the penalty box as investors re-evaluate the company's fundamental outlook. While IPC's performance (12% revenue and 19% EPS growth) is nothing to sneeze at, we also recognize that its risk profile has changed and will likely result in a NT valuation reset.”
IPC The Hospitalist Company closed on Thursday at $41.90.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in